Hansa Biopharma AB (publ) (HNSBF) Financials

HNSBF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 121.0 million 149.7 million
Dec. 31, 2025 126.7 million 135.9 million
Sept. 30, 2025 78.1 million 137.3 million
June 30, 2025 88.6 million 135.2 million

HNSBF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.3 million ?
Dec. 31, 2025 -19.3 million ?
Sept. 30, 2025 -9.4 million ?
June 30, 2025 -11.8 million ?

HNSBF Net Income

No data available :(

HNSBF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 70.4 million 118.0 million 268811
Dec. 31, 2025 76.1 million 85.3 million 1.2 million
Sept. 30, 2025 26.6 million 81.7 million 102380
June 30, 2025 37.5 million 79.7 million 1.2 million

HNSBF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 10.6 million
Dec. 31, 2025 11.1 million
Sept. 30, 2025 9.0 million
June 30, 2025 7.5 million

HNSBF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.0 million 11.0 million -
Dec. 31, 2025 - 8.1 million 11.0 million -
Sept. 30, 2025 - 7.4 million 9.3 million -
June 30, 2025 - 10.1 million 9.6 million -

HNSBF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 3.6 million 1.4 million
Dec. 31, 2025 8.3 million 2.7 million
Sept. 30, 2025 3.2 million 2.1 million
June 30, 2025 5.2 million 1.9 million

HNSBF

Price: $2.90

52 week price:
2.73
4.58

Earnings Per Share: -0.86 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 245.8 million

Links: